The endothelin system: A novel therapeutic target in cardiovascular disease

Emerging Drugs

Volumn 3, Issue , 1998, Pages 95-112

  Strachan, F E ^a   Webb, D J ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

3 (2 CARBOXYMETHOXY 4 METHOXYPHENYL) 1 (3,4 METHYLENEDIOXYPHENYL) 5 PROPOXY 2 INDANCARBOXYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BOSENTAN; CALCIUM ANTAGONIST; CYCLO(DEXTRO TRYPTOPHYL DEXTRO ASPARTYLPROLYL DEXTRO VALYLLEUCYL); DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENDOTHELIN; ENDOTHELIN 1; ENDOTHELIN RECEPTOR ANTAGONIST; SITAXSENTAN; TAK 044; UNCLASSIFIED DRUG;

CARDIOVASCULAR DISEASE; DRUG RESEARCH; HEART INFARCTION; HUMAN; HYPERTENSION; KIDNEY FAILURE; KIDNEY FUNCTION; REVIEW; SUBARACHNOID HEMORRHAGE; VASCULAR ENDOTHELIUM; VASCULAR RESISTANCE; VASODILATATION;

EID: 0031968273     PISSN: 13619195     EISSN: None     Source Type: Journal    
DOI: 10.1517/14728214.3.1.95     Document Type: Review

References (99)